Literature DB >> 18261370

Inhibition of human liver cytochrome P450 by star fruit juice.

Jiang-Wei Zhang1, Yong Liu, Jie Cheng, Wei Li, Hong Ma, Hong-Tao Liu, Jie Sun, Li-Ming Wang, Yu-Qi He, Yun Wang, Zheng-Tao Wang, Ling Yang.   

Abstract

PURPOSE: To examine the inhibitory effects of star fruit (Averrhoa carambola) juice towards seven major cytochrome P450 (CYP) isoforms and NADPH-cytochrome P450 reductase (CPR).
METHODS: The inhibitory effects of star fruit juice (0.5 to 5%, v/v) against the activities of seven CYP isoforms including CYP1A2, CYP2A6, CYP2C8, CYP2C9, CYP2D6, CYP2E1, CYP3A4 and CPR were examined in human liver microsomes. To identify time-dependent inhibition, star fruit juice (2.5%, v/v) was preincubated with microsomes and a NADPH-generating system for 0-15 min, and then the extent of inhibition towards seven CYP isoforms were examined.
RESULTS: Star fruit juice (5.0%, v/v) was found to inhibit all the activities of CYP isoforms tested by more than 70%. Based on the half inhibition values (%, v/v), the inhibitory effects towards different CYP isoforms were in the following order: CYP2A6 (0.9) > CYP1A2 (1.4) > CYP2D6 (1.6) > CYP2E1 (2.0) > CYP2C8 (2.2) > CYP2C9 (3.0) > CYP3A4 (3.2). Time-dependent inhibition was not observed towards any of the tested CYP isoforms. In addition, star fruit juice was found not to inhibit the activity of CPR.
CONCLUSIONS: Star fruit juice inhibited the seven CYP isoforms tested, with the strongest inhibitory effect against CYP2A6 and the least towards CYP3A4.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18261370     DOI: 10.18433/j30593

Source DB:  PubMed          Journal:  J Pharm Pharm Sci        ISSN: 1482-1826            Impact factor:   2.327


  15 in total

1.  Effect of Ginkgo Leaf Tablets on the Pharmacokinetics of Amlodipine in Rats.

Authors:  Rong Wang; Hai Zhang; Sen Sun; Yuanyuan Wang; Yifeng Chai; Yongfang Yuan
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2016-12       Impact factor: 2.441

2.  Inhibitory Effects of Triptolide on Human Liver Cytochrome P450 Enzymes and P-Glycoprotein.

Authors:  Hanhua Zhang; Guangkui Ya; Hongbing Rui
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2017-02       Impact factor: 2.441

3.  In vitro study on the effect of peucedanol on the activity of cytochrome P450 enzymes.

Authors:  Cun Zhang; Yongwei Li; Changlong Yin; Jie Zheng; Guozhi Liu
Journal:  Pharm Biol       Date:  2021-12       Impact factor: 3.503

4.  Analysis of CYP3A inhibitory components of star fruit (Averrhoa carambola L.) using liquid chromatography-mass spectrometry.

Authors:  Shinzo Hosoi; Eri Shimizu; Kazuhiko Arimori; Manabu Okumura; Muneaki Hidaka; Mitsuko Yamada; Akiyo Sakushima
Journal:  J Nat Med       Date:  2008-03-25       Impact factor: 2.343

5.  In vitro inhibitory effects of Friedelin on human liver cytochrome P450 enzymes.

Authors:  Jinlan Wei; Hongying Zhang; Qingling Zhao
Journal:  Pharm Biol       Date:  2018-12       Impact factor: 3.503

6.  Effects of Ginkgo leaf tablets on the pharmacokinetics of losartan and its metabolite EXP3174 in rats and its mechanism.

Authors:  Baiping Dong; Suowei Yuan; Jinsheng Hu; Yanzhen Yan
Journal:  Pharm Biol       Date:  2018-12       Impact factor: 3.503

7.  In vitro inhibitory effects of bergenin on human liver cytochrome P450 enzymes.

Authors:  Gang Dong; Yun Zhou; Xiaoli Song
Journal:  Pharm Biol       Date:  2018-12       Impact factor: 3.503

8.  In vitro inhibitory effect of lysionotin on the activity of cytochrome P450 enzymes.

Authors:  Yang Li; Jing Qin; Hong Wu; Yongmei Xu; Li Zhang; Keren Su; Ying Cui; Haiping Wang
Journal:  Pharm Biol       Date:  2020-12       Impact factor: 3.503

9.  In vitro inhibitory effects of cepharanthine on human liver cytochrome P450 enzymes.

Authors:  Xunge Zhang; Ping Feng; Xinfu Gao; Bin Wang; Chunxia Gou; Ruimin Bian
Journal:  Pharm Biol       Date:  2020-12       Impact factor: 3.503

10.  In vitro inhibitory effects of ganoderic acid A on human liver cytochrome P450 enzymes.

Authors:  Shangchen Xu; Fengqing Zhang; Dali Chen; Keren Su; Li Zhang; Rui Jiang
Journal:  Pharm Biol       Date:  2020-12       Impact factor: 3.503

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.